Global Superdisintegrants Market Size, Trends, By Product Type (Synthetic Superdisintegrants, Natural super disintegrants, and Others), By Formulation (Tablets and Capsules), By Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases, and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa): Global Opportunity Analysis and Industry Forecast, 2023-2030.
Global Superdisintegrants Market
The Global Superdisintegrants Market was valued at US$ 420 Mn in 2022, estimated to reach US$ 700 Mn by 2030, with a CAGR of 4.74% from 2023-2030.
Superdisintegrants are a group of ingredients added to medicine formulations to help tablets or capsules breaks down into smaller pieces of their contents. It is made up of pieces of broken-down tablet parts, such as the insoluble coating on the tablets or the shells of capsules, or it might be any melted fatty material. Superdisintegrating agents can be added before or after the wet granulation step, and they can speed up the swelling of a tablet when it comes into contact with a liquid. Super disintegrants have several qualities, including a high capacity for hydration, excellent molding and flow characteristics, a pleasant mouthfeel, etc. It should also have favorable tableting qualities and be compatible with the other excipients. There are many different kinds of super disintegrants available on the market, including natural and synthetic ones.
Market Drivers
A rise in the generic market development of new superdisintegrants for the pharmaceutical industry is anticipated to boost market growth in the coming years. The rising geriatric population who have trouble with swollen tablets or capsules, increasing R&D activities, and growing R&D investment are anticipated to propel the market expansion in the coming years.
Furthermore, the rising adoption rate of novel drug delivery system technology and orally disintegrating tablets, and the rising acceptance of advanced technologies are major factors boosting the market expansion in the coming years.
Market Restraints
The numerous challenges that the market manufacturer faces include preserving safety and fulfilling the high standards set by regulators, consumers, pharmaceutical manufacturers, and most crucially, patients, as well as achieving maximum transparency and immediate simplification in supply chain operations.
COVID 19 Impact
Governments from all across the world are collaborating with pharmaceutical and biotech businesses to combat the COVID-19 epidemic, from assisting in the creation of vaccinations to preparing for issues with the supply chain for pharmaceuticals. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline.
Furthermore, there has been a sharp increase in demand for regularly used medications such as hydroxychloroquine for the treatment of COVID-19. Such high demand for these treatments has given a tremendous opportunity for manufacturers of COVID-19 management drugs, as many industrialized countries are short of these drugs. The pharmaceutical and biotechnology sector is anticipated to experience significant growth in the coming years as a result of the demand for COVID-19 vaccines and treatment medications.
Market Segmentation
The scope of the Global Superdisintegrants Market covers segmentation based on Product Type, Formulation, Therapeutic Area, and Region.
Based on Product Type, the market is segmented into Synthetic Superdisintegrants, Natural Superdisintegrants, and Others.
Based on Formulation, the market is divided into Tablets and Capsules.
Based on the Therapeutic Area, the market is bifurcated into Oncology, Neurology, Cardiology, Infectious Diseases, and Others.
Regional Analysis
The Global Superdisintegrants Market is segmented into 5 main regions, namely, North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
North America is estimated to hold the major market share in the coming years. A few of the market's heightened primary drivers include an increase in the need for generic medications, enhanced innovation in the creation of super disintegrants, and manufacturing techniques. Additionally, many of the most significant businesses in the superdisintegrants sector are based in North America.
On the other hand, the APAC area is anticipated to grow at the fastest rate during the forecast period. Increased outsourcing of active ingredients, including Superdisintegrants, the creation of new Superdisintegrants, and the acceptance of new technology is likely to be the main drivers of growth in the APAC region. The market may grow during the anticipated timeframe as a result of the region's rising R&D efforts.
Key Players
Ashland Global Holdings Inc, Roquette Frères S.A, FMC Corporation, DFE Pharma, Huber Corporation, Nippon Soda Co., Ltd., The Dow Chemical Company BASF SE, DowDuPont, JRS PHARMA, Asahi Kasei Corporation
Market Taxonomy
By Product Type
• Synthetic superdisintegrants
• Natural superdisintegrants
• Others
By Formulation
• Tablets
• Capsules
By Therapeutic Area
• Oncology
• Neurology
• Cardiology
• Infectious Diseases
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Europe
o Germany
o France
o UK
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Bonsai Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have the highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
Global Superdisintegrants Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Superdisintegrants Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn.
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Superdisintegrants Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Formulation and Services
5.2 Global Superdisintegrants Market Share Analysis, By Product Type
5.3 Global Superdisintegrants Market Size and Forecast, By Product Type
5.3.1 Synthetic Superdisintegrants
5.3.2 Natural Superdisintegrants
5.3.3 Others
6 Global Superdisintegrants Market, By Formulation
6.1 Y-o-Y Growth Comparison, By Formulation
6.2 Global Superdisintegrants Market Share Analysis, By Formulation
6.3 Global Superdisintegrants Market Size and Forecast, By Formulation
6.3.1 Tablets
6.3.2 Capsules
7 Global Superdisintegrants Market, By Therapeutic Area
7.1 Y-o-Y Growth Comparison, By Therapeutic Area
7.2 Global Superdisintegrants Market Share Analysis, By Therapeutic Area
7.3 Global Superdisintegrants Market Size and Forecast, By Therapeutic Area
7.3.1 Oncology, Neurology, Cardiology, Infectious Diseases, and Others
7.3.2 Neurology
7.3.3 Cardiology
7.3.4 Infectious Diseases
7.3.5 Others
8 Global Superdisintegrants Market, By Region
8.1 Global Superdisintegrants Market Share Analysis, By Region
8.2 Global Superdisintegrants Market Size and Forecast, By Region
8.3 Global Superdisintegrants Market Trends and Forecast, By Region
9 North America Superdisintegrants Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Superdisintegrants Market Share Analysis, By Product Type
9.3 North America Superdisintegrants Market Size and Forecast, By Formulation
9.4 North America Superdisintegrants Market Size and Forecast, By Therapeutic Area
9.5 North America Superdisintegrants Market Size and Forecast, By Country
9.5.1 U.S.
9.5.1.1 Market Size and Forecast, By Product Type
9.5.1.2 Market Size and Forecast, By Formulation
9.5.1.3 Market Size and Forecast, By Therapeutic Area
9.5.2 Canada
9.5.2.1 Market Size and Forecast, By Product Type
9.5.2.2 Market Size and Forecast, By Formulation
9.5.2.3 Market Size and Forecast, By Therapeutic Area
9.5.3 Mexico
9.5.3.1 Market Size and Forecast, By Product Type
9.5.3.2 Market Size and Forecast, By Formulation
9.5.3.3 Market Size and Forecast, By Therapeutic Area
10 Europe Superdisintegrants Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Superdisintegrants Market Share Analysis, By Product Type
10.3 Europe Superdisintegrants Market Size and Forecast, By Formulation
10.4 Europe Superdisintegrants Market Size and Forecast, By Therapeutic Area
10.5 Europe Superdisintegrants Market Size and Forecast, By Country
10.5.1 Germany
10.5.1.1 Market Size and Forecast, By Product Type
10.5.1.2 Market Size and Forecast, By Formulation
10.5.1.3 Market Size and Forecast, By Therapeutic Area
10.5.2 France
10.5.2.1 Market Size and Forecast, By Product Type
10.5.2.2 Market Size and Forecast, By Formulation
10.5.2.3 Market Size and Forecast, By Therapeutic Area
10.5.3 UK
10.5.3.1 Market Size and Forecast, By Product Type
10.5.3.2 Market Size and Forecast, By Formulation
10.5.3.3 Market Size and Forecast, By Therapeutic Area
10.5.4. Russia
10.5.4.1 Market Size and Forecast, By Product Type
10.5.4.2 Market Size and Forecast, By Formulation
10.5.4.3 Market Size and Forecast, By Therapeutic Area
10.5.5. Italy
10.5.5.1 Market Size and Forecast, By Product Type
10.5.5.2 Market Size and Forecast, By Formulation
10.5.5.3 Market Size and Forecast, By Therapeutic Area
10.5.6 Spain
10.5.6.1 Market Size and Forecast, By Product Type
10.5.6.2 Market Size and Forecast, By Formulation
10.5.6.3 Market Size and Forecast, By Therapeutic Area
10.5.7 Rest of Europe
10.5.7.1 Market Size and Forecast, By Product Type
10.5.7.2 Market Size and Forecast, By Formulation
10.5.7.3 Market Size and Forecast, By Therapeutic Area
11 Asia Pacific Superdisintegrants Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Superdisintegrants Market Share Analysis, By Product Type
11.3 Asia Pacific Superdisintegrants Market Size and Forecast, By Formulation
11.4 Asia Pacific Superdisintegrants Market Size and Forecast, By Therapeutic Area
11.5 Asia Pacific Superdisintegrants Market Size and Forecast, By Country
11.5.1 China
11.5.1.1 Market Size and Forecast, By Product Type
11.5.1.2 Market Size and Forecast, By Formulation
11.5.1.3 Market Size and Forecast, By Therapeutic Area
11.5.2 Japan
11.5.2.1 Market Size and Forecast, By Product Type
11.5.2.2 Market Size and Forecast, By Formulation
11.5.2.3 Market Size and Forecast, By Therapeutic Area
11.5.3 India
11.5.3.1 Market Size and Forecast, By Product Type
11.5.3.2 Market Size and Forecast, By Formulation
11.5.3.3 Market Size and Forecast, By Therapeutic Area
11.5.4. South Korea
11.5.4.1 Market Size and Forecast, By Product Type
11.5.4.2 Market Size and Forecast, By Formulation
11.5.4.3 Market Size and Forecast, By Therapeutic Area
11.5.5. Australia
11.5.5.1 Market Size and Forecast, By Product Type
11.5.5.2 Market Size and Forecast, By Formulation
11.5.5.3 Market Size and Forecast, By Therapeutic Area
11.5.6. New Zealand
11.5.6.1 Market Size and Forecast, By Product Type
11.5.6.2 Market Size and Forecast, By Formulation
11.5.6.3 Market Size and Forecast, By Therapeutic Area
11.5.7 Singapore
11.5.7.1 Market Size and Forecast, By Product Type
11.5.7.2 Market Size and Forecast, By Formulation
11.5.7.3 Market Size and Forecast, By Therapeutic Area
11.5.8. Malaysia
11.5.8.1 Market Size and Forecast, By Formulation and Services
11.5.8.2 Market Size and Forecast, By Formulation
11.5.8.3 Market Size and Forecast, By Therapeutic Area
11.5.9 Rest of Asia
11.5.9.1 Market Size and Forecast, By Product Type
11.5.9.2 Market Size and Forecast, By Formulation
11.5.9.3 Market Size and Forecast, By Therapeutic Area
12 Latin America Superdisintegrants Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Superdisintegrants Market Share Analysis, By Product Type
12.3 Latin America Superdisintegrants Market Size and Forecast, By Formulation
12.4 Latin America Superdisintegrants Market Size and Forecast, By Therapeutic Area
12.5 Latin America Superdisintegrants Market Size and Forecast, By Country
12.5.1 Brazil
12.5.1.1 Market Size and Forecast, By Product Type
12.5.1.2 Market Size and Forecast, By Formulation
12.5.1.3 Market Size and Forecast, By Therapeutic Area
12.5.2 Argentina
12.5.2.1 Market Size and Forecast, By Product Type
12.5.2.2 Market Size and Forecast, By Formulation
12.5.2.3 Market Size and Forecast, By Therapeutic Area
12.5.3. Colombia
12.5.3.1 Market Size and Forecast, By Product Type
12.5.3.2 Market Size and Forecast, By Formulation
12.5.3.3 Market Size and Forecast, By Therapeutic Area
12.5.4. Peru
12.5.4.1 Market Size and Forecast, By Product Type
12.5.4.2 Market Size and Forecast, By Formulation
12.5.4.3 Market Size and Forecast, By Therapeutic Area
12.5.5 Chile
12.5.5.1 Market Size and Forecast, By Product Type
12.5.5.2 Market Size and Forecast, By Formulation
12.5.5.3 Market Size and Forecast, By Therapeutic Area
12.5.6 Venezuela
12.5.6.1 Market Size and Forecast, By Product Type
12.5.6.2 Market Size and Forecast, By Formulation
12.5.6.3 Market Size and Forecast, By Therapeutic Area
12.5.7 Rest of Latin America
12.5.7.1 Market Size and Forecast, By Product Type
12.5.7.2 Market Size and Forecast, By Formulation
12.5.7.3 Market Size and Forecast, By Therapeutic Area
13 Middle East Superdisintegrants Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Superdisintegrants Market Share Analysis, By Product Type
13.3 Middle East Superdisintegrants Market Size and Forecast, By Formulation
13.4 Middle East Superdisintegrants Market Size and Forecast, By Therapeutic Area
13.5 Middle East Superdisintegrants Market Size and Forecast, By Country
13.5.1 Saudi Arabia
13.5.1.1 Market Size and Forecast, By Product Type
13.5.1.2 Market Size and Forecast, By Formulation
13.5.1.3 Market Size and Forecast, By Therapeutic Area
13.5.2 UAE
13.5.2.1 Market Size and Forecast, By Product Type
13.5.2.2 Market Size and Forecast, By Formulation
13.5.2.3 Market Size and Forecast, By Therapeutic Area
13.5.3 Egypt
13.5.3.1 Market Size and Forecast, By Product Type
13.5.3.2 Market Size and Forecast, By Formulation
13.5.3.3 Market Size and Forecast, By Therapeutic Area
13.5.4 Kuwait
13.5.4.1 Market Size and Forecast, By Product Type
13.5.4.2 Market Size and Forecast, By Formulation
13.5.4.3 Market Size and Forecast, By Therapeutic Area
13.5.5 South Africa
13.5.5.1 Market Size and Forecast, By Product Type
13.5.5.2 Market Size and Forecast, By Formulation
13.5.5.3 Market Size and Forecast, By Therapeutic Area
13.5.5 Rest of Middle East & Africa
13.5.6.1 Market Size and Forecast, By Product Type
13.5.6.2 Market Size and Forecast, By Formulation
13.5.6.3 Market Size and Forecast, By Therapeutic Area
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Ashland Global Holdings Inc
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Roquette Frères S.A
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 FMC Corporation
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 DFE Pharma
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Huber Corporation
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Nippon Soda Co., Ltd.
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 The Dow Chemical Company BASF SE
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 DowDuPont
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 JRS PHARMA
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Asahi Kasei Corporation
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
